US FDA aims to give full approval to Pfizer vaccine on Monday

The approval could boost the vaccination campaign by convincing more unvaccinated Americans that Pfizer's shot is safe and effective and also make local officials more comfortable in implementing vaccine mandates.

WASHINGTON: The U.S. Food and Drug Administration is aiming to give full approval to Pfizer's COVID-19 vaccine on Monday, the New York Times reported.

Regulators were aiming to complete the process by Friday, but were still working through "a substantial amount of paperwork and negotiation with the company," the Times said, citing people familiar with the planning who were not authorized to speak publicly about it.